Literature DB >> 15551573

Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres.

M Bardiès1, J F Chatal.   

Abstract

We calculated the mean absorbed fractions, specific absorbed fractions and mean doses per unit of cumulated activity in source spheres 10 microm-2 cm in radius for 22 beta-emitting radionuclides potentially useful in radioimmunotherapy. We considered two models of radionuclide distribution, either uniform at the surface of the source or throughout its volume. For each model, we calculated both the absorbed fractions in the spherical segments composing the source and the mean absorbed fractions. For surface distribution, we calculated the mean dose per unit of cumulated activity for a concentric sphere with a small radius (5 microm) in order to determine the minimal dose delivered to the target. Calculations were performed using point kernels for monoenergetic emissions and then integrated into the beta spectra of the different emitters (32p, 33p, 47Sc, 67Cu, 77As, 90Y, 105Rh, 109Pd, 111Ag, 121Sn, 131I, 142Pr, 143Pr, 149Pm, 153Sm, 159Gd, 166Ho, 177Lu, 186Re, 188Re, 194Ir and 199Au). Monoenergetic emissions were taken into account. Results are reported in the form of tables to facilitate use during dosimetric studies for radioimmunotherapy. An application is presented showing the potential utility of associating emitters with different energies in order to sterilize a range of tumour targets of variable size.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 15551573     DOI: 10.1088/0031-9155/39/6/004

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  14 in total

1.  Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer.

Authors:  F Kraeber-Bodéré; A Mishra; P Thédrez; A Faivre-Chauvet; M Bardiès; S Imai; J Le Boterff; J F Chatal
Journal:  Eur J Nucl Med       Date:  1996-05

2.  124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET.

Authors:  Joseph A O'Donoghue; Peter M Smith-Jones; John L Humm; Shutian Ruan; Daniel A Pryma; Achim A Jungbluth; Chaitanya R Divgi; Jorge A Carrasquillo; Neeta Pandit-Taskar; Yuman Fong; Vivian E Strong; Nancy E Kemeny; Lloyd J Old; Steven M Larson
Journal:  J Nucl Med       Date:  2011-11-08       Impact factor: 10.057

3.  Calculation of electron dose to target cells in a complex environment by Monte Carlo code "CELLDOSE".

Authors:  Elif Hindié; Christophe Champion; Paolo Zanotti-Fregonara; Domenico Rubello; Nicole Colas-Linhart; Laura Ravasi; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-09       Impact factor: 9.236

4.  A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.

Authors:  Robert F Hobbs; Sébastien Baechler; De-Xue Fu; Caroline Esaias; Martin G Pomper; Richard F Ambinder; George Sgouros
Journal:  Med Phys       Date:  2011-06       Impact factor: 4.071

5.  Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy.

Authors:  Neeta Pandit-Taskar; Joseph A O'Donoghue; Michael J Morris; Eze A Wills; Lawrence H Schwartz; Mithat Gonen; Howard I Scher; Steven M Larson; Chaitanya R Divgi
Journal:  J Nucl Med       Date:  2008-06-13       Impact factor: 10.057

6.  Cerenkov Luminescence Imaging for Radiation Dose Calculation of a ⁹⁰Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist.

Authors:  Christian Lohrmann; Hanwen Zhang; Daniel L J Thorek; Pooja Desai; Pat B Zanzonico; Joseph O'Donoghue; Christopher P Irwin; Thomas Reiner; Jan Grimm; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2015-04-03       Impact factor: 10.057

7.  Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.

Authors:  Dongyoul Lee; Mengshi Li; Bryan Bednarz; Michael K Schultz
Journal:  Radiat Res       Date:  2018-06-26       Impact factor: 2.841

8.  Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy.

Authors:  Kwanghee Kim; Hanwen Zhang; Stephen La Rosa; Sylvia Jebiwott; Pooja Desai; Simon Kimm; Avigdor Scherz; Joseph A O'Donoghue; Wolfgang A Weber; Jonathan A Coleman
Journal:  Clin Cancer Res       Date:  2017-01-20       Impact factor: 12.531

9.  Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide.

Authors:  Eric Frampas; Catherine Maurel; Patricia Remaud-Le Saëc; Thibault Mauxion; Alain Faivre-Chauvet; François Davodeau; David M Goldenberg; Manuel Bardiès; Jacques Barbet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-20       Impact factor: 9.236

10.  Effect of emaciation and obesity on small-animal internal radiation dosimetry for positron-emitting radionuclides.

Authors:  Tianwu Xie; Habib Zaidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-02       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.